Healthcare -
Biotechnology - NASDAQ - US
$ 2.28
-3.8 %
$ 60.5 M
Market Cap
-2.13
P/E
GANX - SHORT-TERM DEBT
Short-term Debt GANX - Gain Therapeutics, Inc.
348 K
LAST VALUE
-19.82%
2 YEAR CAGR
28.99%
5 YEAR CAGR
0.00%
10 YEAR CAGR